Annovis Bio, Inc. Shares Outstanding (Cover Page)
Annovis Bio, Inc. (ANVS) had Shares Outstanding (Cover Page) of 42.61 million shares as of 2026-08-14, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-14: Entity Common Stock, Shares Outstanding 42.61M shares.
- 2026-05-15: Entity Common Stock, Shares Outstanding 34.65M shares.
- 2026-03-12: Entity Common Stock, Shares Outstanding 28.36M shares.
- 2025-11-12: Entity Common Stock, Shares Outstanding 26.50M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-14 | 42.61M shares 10-Q · filed 2026-08-14 |
| 2026-05-15 | 34.65M shares 10-Q · filed 2026-05-15 |
| 2026-03-12 | 28.36M shares 10-K · filed 2026-03-13 |
| 2025-11-12 | 26.50M shares 10-Q · filed 2025-11-12 |
| 2025-08-08 | 19.49M shares 10-Q · filed 2025-08-12 |
| 2025-05-09 | 19.49M shares 10-Q · filed 2025-05-13 |
| 2025-03-18 | 19.49M shares 10-K · filed 2025-03-21 |
| 2024-11-06 | 13.80M shares 10-Q · filed 2024-11-08 |
| 2024-08-09 | 13.05M shares 10-Q · filed 2024-08-14 |
| 2024-05-09 | 11.17M shares 10-Q · filed 2024-05-10 |
| 2024-03-26 | 11.01M shares 10-K · filed 2024-03-29 |
| 2023-11-06 | 10.26M shares 10-Q · filed 2023-11-08 |
| 2023-08-11 | 9.01M shares 10-Q · filed 2023-08-14 |
| 2023-05-08 | 9.01M shares 10-Q · filed 2023-05-10 |
| 2023-03-30 | 8.22M shares 10-K · filed 2023-03-31 |
| 2022-11-04 | 8.16M shares 10-Q · filed 2022-11-08 |
| 2022-08-05 | 8.16M shares 10-Q · filed 2022-08-08 |
| 2022-05-02 | 8.16M shares 10-Q · filed 2022-05-04 |
| 2022-02-28 | 8.16M shares 10-K · filed 2022-03-02 |
| 2021-11-01 | 8.10M shares 10-Q · filed 2021-11-03 |
| 2021-07-26 | 8.10M shares 10-Q · filed 2021-07-28 |
| 2021-05-04 | 6.95M shares 10-Q · filed 2021-05-06 |
| 2021-03-01 | 6.95M shares 10-K · filed 2021-03-03 |
| 2020-11-02 | 6.89M shares 10-Q · filed 2020-11-04 |
| 2020-07-28 | 6.87M shares 10-Q · filed 2020-07-29 |
| 2020-04-30 | 6.86M shares 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |